510(k) Report

510(k) · Cleared

Cleared

Senographe Essential, Premium View I (Pvi)

K131885510(k) TraditionalCleared Sep 26, 201393-day reviewClass II21 CFR 892.1715

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

GE Medical Systems SCS · MUE Full Field Digital, System, X-Ray, Mammographic

Cleared on Sep 26, 2013 as substantially equivalent to P990066 (GE Healthcare, 2000) and 1 other predicate after a 93-day review. Its family tree reaches back 2 generations to 2000.

Decided
Sep 26, 2013
Review
93 days
Class
Class II
Product code
MUE
Recalls
None
Predicates
2

Its longest line of descent runs back 2 generations to P990066 (2000). No later device cites it as a predicate yet.

  1. Root · 2 generations backP990066 GE Healthcare Senographe Full Field Digital Mammography SystemGE Healthcare · 2000 · Recalled
  2. 1 generation backK110798 Senographe DS, Senographe EssentialGeneral Electric Company · 2011
  3. This deviceK131885 Senographe Essential, Premium View I (Pvi)GE Medical Systems SCS · 2013
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2P990066GE Healthcare Senographe Full Field Digital Mammography SystemGE Healthcare20004
−1K110798Senographe DS, Senographe EssentialGeneral Electric Company2011—
0 (this device)K131885Senographe Essential, Premium View I (Pvi)GE Medical Systems SCS2013—
FIG. 1 — Lineage of K131885, 2000–2013Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MUE? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MUE device

  1. #1 K253678 MAMMOMAT B.brilliant (11372950)score 13.6 · 8 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*P990066GE Healthcare Senographe Full Field Digital Mammography System
Summary page 1
…Digital Mammography System Classification Names: 21 CFR 892.1715, Class 11 Product Code: MUE Predicate Devicels): Senographe Essential -P990066/S 21 with Premium View K110798 5-2 === Page 2 ==…
GE Healthcare20004
*K110798Senographe DS, Senographe Essential
Summary page 1
…FR 892.1715, Class 11 Product Code: MUE Predicate Devicels): Senographe Essential -P990066/S 21 with Premium View K110798 5-2 GE Healthcare 510(k) Premoarket Notification Submission…
General Electric Company2011—

Also cleared against P990066: 5 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 13 years and passes through 3 companies; a new generation was cleared every 11.9 years on median.
  • 1 of the 2 ancestors has a recall of any class.
  • 5 other devices also cite its predicate P990066.

How does its category compare?

All MUE devices

MUE Full Field Digital, System, X-Ray, Mammographic: FDA decisions, review times, recalls and adverse event reports over 20 years. 2013, this device’s year, is highlighted.

FDA decisions per year · MUE

3in 2025

2007: 62008: 52009: 82010: 102011: 102012: 42013: 72014: 12015: 12016: 12017: 82018: 22019: 22020: 42021: 42022: 32023: 12024: 12025: 32026 (partial year): 4
2007high 10 (2010) · low 1 (2014)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MUE

255in 2025

2011: 192 days median2012: 123 days median2013: 207 days median2017: 95 days median2020: 188 days median2021: 164 days median2022: 404 days median2025: 255 days median2026 (partial year): 185 days median
2007high 404 (2022) · low 95 (2017)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MUE

4in 2025

2008: 12009: 12010: 22011: 52014: 22017: 62018: 12019: 12023: 12025: 42026 (partial year): 1
2007high 6 (2017) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MUE

40in 2025

2008: 42009: 32010: 22011: 102012: 62013: 112014: 72015: 62016: 192017: 1152018: 1452019: 802020: 492021: 252022: 362023: 292024: 332025: 40
2007high 145 (2018) · low 0 (2007)2025

MAUDE reports naming product code MUE, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20076—00
20085—14
20098—13
201010—22
201110192510
2012412306
20137207011
20141—27
20151—06
20161—019
20178956115
20182—1145
20192—180
20204188049
20214164025
20223404036
20231—129
20241—033
20253255440
202641851—

What is it indicated for?

The Senographe Essential FFDM systems generate digital mammographic images that can be used for screening and in the diagnosis of breast cancer. The Senographe Essential FFDM systems are intended to be used in the same clinical applications as traditional film-based mammographic systems. Premium View is an image-processing algorithm, which increases the visibility of breast structures. The main advantage is to provide a single breast image, where the…

Read the full statement (225 words)

The Senographe Essential FFDM systems generate digital mammographic images that can be used for screening and in the diagnosis of breast cancer. The Senographe Essential FFDM systems are intended to be used in the same clinical applications as traditional film-based mammographic systems.

Premium View is an image-processing algorithm, which increases the visibility of breast structures. The main advantage is to provide a single breast image, where the contrast in the fatty tissues is similar to that obtained by setting WW (window width) and WL (window level) for optimum visualization of fatty tissues, and the contrast in the fibro-glandular tissue is similar to that obtained by setting WW and WL for optimal visualization of fibro-glandular tissues.

PVI is an option that can simplify the presentation of mammographic images, improve workflow, and streamline the review process of images with very dark or bright areas by presenting the image with the WW and WL optimized for review with minimal need for the user to make adjustments for the various tissue areas. This could be especially useful with patients who have very thin breasts, very dense breasts. or implants that currently require multiple adjustments of WW and WL to review.

eContrast accommodates different customer display preferences in screening and diagnosis, with 5 different levels, while keeping the PVi option for implants. eContrast postprocessing is also available for stereo images.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K131885: Senographe Essential, Premium View I (Pvi).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K131885

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026